Document:

EXHIBIT 10.10

 

CONSULTING
AGREEMENT

 

This
Consulting Agreement (the “Agreement”) is made and entered into as of June 2, 2013 (the “Effective
Date”), by and between Medical Cash Management Solutions, LLC, a
New York limited liability company (“MCMS”),
and Neurotrope BioScience, Inc., a Delaware corporation (“Neurotrope”).

 

RECITALS

 

Whereas,
Neurotrope desires to engage MCMS, and MCMS desires to accept the engagement by Neurotrope,
to act as a consultant to Neurotrope under the terms and conditions set forth in this Agreement. 

 

Now,
Therefore, in consideration of the mutual covenants contained herein, and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

AGREEMENT

 

1.            Consulting
Services. Subject to the terms and conditions of
this Agreement, effective as of the date hereof, Neurotrope
hereby engages MCMS, and MCMS hereby accepts the engagement by Neurotrope, to act as a consultant to Neurotrope for the duration
of the Term (as defined below). In its capacity as a consultant to Neurotrope, MCMS agrees to perform the services identified in
Appendix A and such other services relating to Neurotrope’s business and operations as are reasonably requested
from time to time by Neurotrope's chief executive officer or board of directors (collectively, the “Services”).
The manner and means by which MCMS chooses to perform the Services shall be in the discretion and control of MCMS; provided,
however, that MCMS shall cause all Services to be performed by Robert Weinstein, a managing member of MCMS ("Weinstein"),
and provided, further, that MCMS shall perform all Services in a timely and professional manner, using a degree of
skill and care at least consistent with industry standards. 

 

2.            Compensation.
As consideration for MCMS’s performance of the Services, Neurotrope shall pay
to MCMS $20,000 (twenty thousand dollars) per month (the "Consulting Fees"), in arrears, with $10,000
(ten thousand dollars) paid on the 15th day of each month and $10,000 (ten thousand dollars) at the end of each month
for the entire Term of this Agreement or until its earlier termination pursuant to Section 8 hereof.

 

3.            Expenses.
Neurotrope shall reimburse MCMS for any reasonable out-of-pocket expenses, including, without
limitation, reasonable travel expenses, incurred in connection with MCMS’s performance of the Services; provided,
however, that MCMS must submit such written documentation of all such expenses as Neurotrope may reasonably require.
Neurotrope will reimburse MCMS for expenses covered by this Section 3 within fifteen (15) days of the date that MCMS submits proper
documentation of such expenses to Neurotrope.

 

    	1

    	 

    

 

4.            Independent
Contractor Relationship. MCMS’s relationship with Neurotrope shall be solely that of
an independent contractor, and nothing in this Agreement shall be construed to create a partnership, joint venture, or employer-employee
relationship. MCMS is not the agent of Neurotrope and is not authorized to make any representation, contract or commitment on behalf
of Neurotrope. MCMS shall not be entitled to any of the benefits that Neurotrope may make available to its employees, such as group
insurance, profit sharing or retirement benefits. MCMS shall be solely responsible for all tax returns and payments required to
be filed with or made to any federal, state or local tax authority with respect to MCMS’s performance of the Services and
receipt of the Consulting Fees pursuant to this Agreement. Neurotrope will regularly report amounts paid to MCMS by filing Form
1099-MISC with the Internal Revenue Service as required by law, but given that MCMS is an independent contractor, Neurotrope will
not withhold or make payments for social security, make unemployment insurance or disability insurance contributions, or obtain
worker’s compensation insurance on MCMS’s behalf. MCMS agrees to accept exclusive liability for complying with all
applicable federal, state and local laws governing self-employed individuals, including, without limitation, obligations such as
payment of taxes, social security, disability and other contributions based on the Consulting Fees paid to MCMS. MCMS hereby agrees
to indemnify, hold harmless and defend Neurotrope from and against any and all such taxes and contributions, as well as any penalties
and interest arising therefrom. 

 

5.            Information
and Intellectual Property Rights.

 

5.1            Proprietary
Information. MCMS agrees that, during the Term and thereafter, MCMS shall take all steps
necessary to hold the Proprietary Information (as defined below) in trust and confidence, shall not use such Proprietary Information
in any manner or for any purpose except as expressly set forth in this Agreement and shall not disclose any such Proprietary Information
to any third party without first obtaining Neurotrope’s express written consent on a case-by-case basis; provided,
however, that MCMS may disclose certain Proprietary Information, without violating its obligations under this Agreement,
to the extent such disclosure is required by a valid order of a court or other governmental body having jurisdiction, provided
that MCMS provides Neurotrope with reasonable prior written notice of such disclosure and uses commercially reasonable efforts
to obtain, or to assist Neurotrope in obtaining, a protective order preventing or limiting the disclosure and/or requiring that
the Proprietary Information so disclosed be used only for the purposes for which the law or regulation required, or for which the
order was issued. For purposes of this Agreement, “Proprietary Information” means any and all confidential
and/or proprietary information regarding Neurotrope or any of its affiliates and their current and proposed business and operations,
including, without limitation, information pertaining to their current or forecasted capital structure, equity or debt financing
or investment activities, strategic plans, current or proposed products or services, investors, employees, directors, consultants,
and other business and contractual relationships; provided, however, that information received by MCMS shall not
be considered to be Proprietary Information if MCMS can demonstrate with competent evidence that such information has been published
or is otherwise readily available to the public other than by a breach of this Agreement.

 

    	2

    	 

    

 

5.2            Third-Party
Information. MCMS understands that Neurotrope has received and will in the future receive
from third parties certain confidential or proprietary information relating to such third parties (collectively, “Third-Party
Information”), subject to duties on Neurotrope’s part to maintain the confidentiality of such Third-Party Information
and to use such Third-Party Information only for certain limited purposes. MCMS agrees to hold all Third-Party Information in confidence
and not to disclose to anyone (other than personnel of Neurotrope) or to use, except in connection with MCMS’s performance
of the Services, any Third-Party Information unless expressly authorized in writing by an executive officer of Neurotrope.

 

5.3            Intellectual
Property Rights. MCMS agrees that any and all intellectual property and intellectual property
rights that MCMS conceived, reduced to practice or developed during the course of its performance of services as a director, officer,
employee or consultant for Neurotrope, together with any and all intellectual property and intellectual property rights that MCMS
conceives, reduces to practice or develops during the course of its performance of the Services pursuant to this Agreement, in
each case whether alone or in conjunction with others (all of the foregoing being collectively referred to herein as the “Inventions”),
shall be the sole and exclusive property of Neurotrope. Accordingly, MCMS hereby: (i) assigns and agrees to assign to Neurotrope
its entire right, title and interest in and to all Inventions; and (ii) designates Neurotrope as its agent for, and grants to the
officers of Neurotrope a power of attorney (which power of attorney shall be deemed coupled with an interest) with full power of
substitution solely for the purpose of, effecting the foregoing assignments from MCMS to Neurotrope. MCMS further agrees to cooperate
with and provide reasonable assistance to Neurotrope to obtain and from time to time enforce any and all current or future intellectual
property rights covering or relating to the Inventions in any and all jurisdictions. 

 

6.            No
Conflicting Obligation.  MCMS
represents that its entering into this Agreement, its performance of all of the terms of this Agreement and its performance of
the Services pursuant to this Agreement do not and will not breach or conflict with any agreement or other arrangement between
MCMS and any third party. During the Term, MCMS agrees not to enter into any agreement that conflicts with this Agreement. Notwithstanding
the foregoing, during the Term, Weinstein may consult (directly or as an agent of MCMS) with other companies as a financial
advisor or CFO provided these companies are not in direct competition with Neurotrope. Weinstein also may (i) serve on civic
or charitable boards or committees, (ii) deliver lectures, (iii) fulfill speaking engagements, (iv) teach at educational
institutions, and (v) manage personal investments; provided that such activities do not individually or in the aggregate directly
interfere with the performance of Weinstein's or MCMS’s duties under this Agreement. Subject to the prior written consent
of the board of directors which request will not be unreasonably denied, Weinstein may also serve as a director of any company
or business that does not directly compete with Neurotrope provided that such activities do not individually or in the aggregate
interfere with the performance of Weinstein's or MCMS’s duties under this Agreement.

 

    	3

    	 

    

 

7.            Indemnification
and Insurance Related to Employment by the Company. 

 

Neurotrope shall indemnify
MCMS and hold MCMS harmless from and against any claim, loss or cause of action arising from or out of MCMS’s performance
after the Effective Date (and within the scope of his responsibilities) as a consultant of Neurotrope or any of its subsidiaries
or other affiliates or predecessors or in any other capacity, including any fiduciary capacity, in which MCMS serves at Neurotrope’s
request, in each case to the maximum extent permitted by law and, to the extent more favorable, to the maximum extent permitted
under Neurotrope’s organizational documents. Notwithstanding the foregoing, Neurotrope shall have no obligation of indemnification
(including advancement of expenses) with respect to conduct, actions or omissions attributable to the gross negligence, willful
or reckless misconduct or malfeasance of MCMS or with respect to conduct, actions or omissions of MCMS occurring after the expiration
of the Term of this Agreement or its earlier termination pursuant to Section 8 hereof. Neurotrope shall, consistent with applicable
laws, provide for the advancement to MCMS, within ten (10) days of its presentation of invoices or other appropriate documentation,
of expenses incurred or sustained in connection with any action, suit or proceeding to which MCMS or its legal representatives
may be made a party by reason of its being or having been a consultant of Neurotrope or any of its subsidiaries or other affiliates
or predecessors or his being or having been engaged in any other capacity at Neurotrope’s request. The rights under this
Section 7 shall in all cases be on terms no less favorable to MCMS than to other consultants of Neurotrope and shall survive the
termination or expiration of this Agreement until the expiration of the applicable statute of limitations.

 

8.            Term
and Termination.

 

8.1            Term.
This Agreement shall commence on the date hereof and shall continue until November 30, 2013 (the “Initial Term”).
At the end of such Initial Term, this Agreement shall terminate unless extended for one or more additional periods (each, a “Renewal
Term”) by mutual written agreement of the parties. The Initial Term and all Renewal Terms, if any, are collectively
referred to herein as the “Term”.

 

8.2            Automatic
Termination. This Agreement shall automatically terminate at any time during the Term upon
the event of (a) Weinstein ceasing to be the managing member of MCMS or (b) Weinstein's death.

 

8.3            Voluntary
Termination. Either party may voluntarily terminate this Agreement by delivering thirty (30)
days prior written notice to the other party.

 

8.4            Termination
by Neurotrope. Neurotrope may terminate this Agreement at any time during the Term upon delivery
to MCMS of notice of the good-faith determination by the majority of the members of the board of directors of Neurotrope (and the
accompanying justification therefore) that such Agreement should be terminated for Cause (as defined below) or as a result of Disability
(as defined below) of Weinstein. For purposes of this Agreement:

 

(a)            The
term “Cause” shall mean: (i) the willful misconduct of MCMS or any of MCMS’s employees, officers
or agents; (ii) MCMS’s willful failure to perform the Services; (iii) the causing of intentional damage to the tangible or
intangible property of Neurotrope by MCMS or any of MCMS’s employees, officers or agents; (iv) the conviction of Weinstein
of any felony or any other crime involving moral turpitude; (v) the performance of any dishonest or fraudulent act by MCMS or any
of MCMS’s employees, officers or agents which is, or would be, in each case as determined in good faith by the board of directors
of Neurotrope materially detrimental to the best interests of Neurotrope or its stockholders or affiliates; or (vi) a breach of
the Agreement by MCMS.

 

    	4

    	 

    

 

(b)            The
term “Disability” shall mean Weinstein’s inability to perform the Services for any period of thirty
(30) consecutive days (or any sixty (60) days during any period of twelve (12) consecutive months) by reason of any physical or
mental incapacity or illness, as determined by the board of directors of Neurotrope based upon medical advice provided by a licensed
physician mutually acceptable to the board of directors of Neurotrope and Weinstein.

 

8.5            Effect
of Termination. The obligations set forth in Sections 4, 5, 6, 8.5 and 9, as well as any
outstanding payment or reimbursement obligations of Neurotrope, shall survive any termination or expiration of this Agreement.
Upon any termination or expiration of this Agreement and at the written request of Neurotrope, MCMS shall promptly deliver to Neurotrope
all documents and other materials of any nature pertaining to the Services, together with all documents and other items containing
or pertaining to any Proprietary Information, Third-Party Information or Inventions.

 

9.            Miscellaneous.

 

9.1            Notices.
All notices and other communications given or made pursuant hereto shall be in writing and shall be deemed effectively given: (i)
upon personal delivery to the party to be notified; (ii) when sent by confirmed electronic mail or facsimile if sent during normal
business hours of the recipient; if not, then on the next business day; (iii) five (5) business days after having been sent by
registered or certified mail, return receipt requested, postage prepaid; or (iv) one (1) business day after deposit with a nationally
recognized overnight courier, specifying next-day delivery, with written verification of receipt. All communications shall be sent
to the respective parties at the following addresses (or at such other addresses as shall be specified by notice given in accordance
with this Section 9.1):

 

	If to MCMS:	Medical Cash Management Solutions, LLC
	 	c/o Robert Weinstein
	 	60 Hampden Lane
	 	Irvington, New York 10533
	 	 
	 	 
	If to Neurotrope:	Neurotrope BioScience, Inc. 
	 	10732 Hawk’s Vista St.
	 	Plantation, Florida 33324
	 	Attn: Dr. Jim New
	 	President and CEO
	 	Fax: 954-452-4656

 

    	5

    	 

    

 

Copy to (which shall not constitute
notice):

 

	 	Bilzin Sumberg Baena Price & Axelrod LLP
	 	1450 Brickell Ave, 23rd Floor
	 	Miami, FL 33131
	 	Attn: Laura Vaughn
	 	Fax: (305) 351-2272

            

9.2            Headings.
The bold-face headings contained in this Agreement are for convenience of reference only, shall not be deemed to be a part of this
Agreement and shall not be referred to in connection with the construction or interpretation of this Agreement.

 

9.3            Governing
Law; Jurisdiction and Venue. This Agreement shall be construed in accordance with, and governed
in all respects by, the internal laws of the State of New York without giving effect to its principles of conflicts of laws. Any
legal action or other legal proceeding relating to this Agreement or the enforcement of any provision of this Agreement shall be
brought or otherwise commenced exclusively in any state or federal court located in the State of New York. Each of the parties
hereto: (i) expressly and irrevocably consents and submits to the jurisdiction of each state and federal court located in the State
of New York, in connection with any legal proceeding; (ii) agrees that service of any process, summons, notice or document by U.S.
mail addressed to such party at the address set forth in Section 8.2 shall constitute effective service of such process, summons,
notice or document for purposes of any such legal proceeding; (iii) agrees that each state and federal court located in the State
of New York, shall be deemed to be a convenient forum; and (iv) agrees not to assert, by way of motion, as a defense or otherwise,
in any such legal proceeding commenced in any state or federal court located in the State of New York, any claim that it is not
subject personally to the jurisdiction of such court, that such legal proceeding has been brought in an inconvenient forum, that
the venue of such proceeding is improper or that this Agreement or the subject matter of this Agreement may not be enforced in
or by such court. 

 

9.4            Successors
and Assigns. The rights and liabilities of the parties hereto shall bind and inure to the
benefit of their respective successors, heirs, executors and administrators, as the case may be; provided, however,
that, as Neurotrope has specifically contracted for MCMS’s Services, which Services are unique and personal, MCMS may
not assign or delegate its obligations under this Agreement either in whole or in part to any other contractor, subcontractor,
business or entity without the prior written consent of Neurotrope. Neurotrope may assign its rights and obligations hereunder
to any person or entity who succeeds to all or substantially all of Neurotrope’s business.

 

9.5            Remedies
Cumulative; Specific Performance. The rights and remedies of the parties hereto shall be
cumulative and not alternative. The parties agree that, in the event of any breach or threatened breach by any party to this Agreement
of any covenant, obligation or other provision set forth in this Agreement for the benefit of any other party to this Agreement,
such other party shall be entitled, in addition to any other remedy that may be available to it, to: (i) a decree or order of specific
performance or mandamus to enforce the observance and performance of such covenant, obligation or other provision; and (ii) an
injunction restraining such breach or threatened breach. The parties further agree that no person or entity shall be required to
obtain, furnish or post any bond or similar instrument in connection with or as a condition to obtaining any remedy referred to
in this Section 8.6, and the parties irrevocably waive any right they may have to require the obtaining, furnishing or posting
of any such bond or similar instrument.

 

    	6

    	 

    

 

9.6            Waiver.
No failure on the part of any person or entity to exercise any power, right, privilege or remedy under this Agreement, and no delay
on the part of any person or entity in exercising any power, right, privilege or remedy under this Agreement, shall operate as
a waiver of such power, right, privilege or remedy and no single or partial exercise of any such power, right, privilege or remedy
shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy. No person or entity shall
be deemed to have waived any claim arising out of this Agreement, or any power, right, privilege or remedy under this Agreement,
unless the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written instrument duly executed
and delivered on behalf of such person or entity, and any such waiver shall not be applicable or have any effect except in the
specific instance in which it is given.

 

9.7            Amendments.
This Agreement may not be amended, modified, altered or supplemented other than by means of a written instrument duly executed
and delivered on behalf of all of the parties hereto.

 

9.8            Severability.
If one or more provisions of this Agreement are held to be unenforceable under applicable law, the parties agree to renegotiate
such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement in writing
for such provision, then: (i) such provision shall be excluded from this Agreement; (ii) the balance of the Agreement shall be
interpreted as if such provision were so excluded; and (iii) the balance of the Agreement shall be enforceable in accordance with
its terms.

 

9.9            Counterparts.
This Agreement may be executed in any number of counterparts, each of which shall be deemed an original and all of which together
shall constitute one and the same instrument.

 

9.10            Entire
Agreement. This Agreement sets forth the entire understanding of the parties hereto relating
to the subject matter hereof and thereof and supersede all prior agreements and understandings among or between any of the parties
relating to the subject matter hereof and thereof.

 

 

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

    	7

    	 

    

In
Witness Whereof, the parties hereto have executed this Consulting Agreement
as of the date first written above.

 

	Medical Cash Management Solutions, LLC	 	Neurotrope BioScience, Inc.
	
         

         

         

        /s/ Robert Weinstein

        Robert Weinstein

        Managing Member
	 	
         

         

         

        /s/
        James S. New

        James S. New

        Chief Executive Officer

 

            

 

 

 

    	8

    	 

    

Appendix
A

sERVICES

 

MCMS shall serve as Chief Financial Officer
(“CFO”) of Neurotrope and shall perform all duties typically performed by the CFO of a similarly situated company.
During the Term, Weinstein shall devote at least three days per week to the performance of such duties for Neurotrope.

 

 

 

 

 

    	9Exhibit 10.11

 

NEUROTROPE, INC.

 

2013 EQUITY INCENTIVE PLAN

 

1.Purposes of
the Plan. The purposes of this Plan are:

 

		·	to attract and retain the best available personnel for positions of substantial responsibility,

 

		·	to provide incentives to individuals who perform services for the Company, and

 

		·	to promote the success of the Company’s business.

 

The Plan permits the
grant of Incentive Stock Options, Nonstatutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units,
Performance Units, Performance Shares and other stock or cash awards as the Administrator may determine.

 

2.Definitions.
As used herein, the following definitions will apply:

 

(a)“Administrator”
means the Board or any of its Committees as will be administering the Plan, in accordance with Section 4 hereof.

 

(b)“Affiliate”
means any corporation or any other entity (including, but not limited to, partnerships and joint ventures) controlling, controlled
by, or under common control with the Company.

 

(c)“Applicable
Laws” means the requirements relating to the administration of equity-based awards under U.S. federal and state corporate
laws, U.S. federal and state securities laws, the Code, any stock exchange or quotation system on which the Common Stock is listed
or quoted and the applicable laws of any foreign country or jurisdiction where Awards are, or will be, granted under the Plan.

 

(d)“Award”
means, individually or collectively, a grant under the Plan of Options, Stock Appreciation Rights,
Restricted Stock, Restricted Stock Units, Performance Units, Performance Shares and other stock or cash
awards as the Administrator may determine.

 

(e)“Award
Agreement” means the written agreement setting forth the terms and provisions applicable to each Award granted under
the Plan. The Award Agreement is subject to the terms and conditions of the Plan.

 

(f)“Board”
means the Board of Directors of the Company.

 

(g)“Change
in Control” means the occurrence of any of the following events:

 

		(i)	A change in the ownership of the Company which occurs on the date that any one person, or
more than one person acting as a group (“Person”), acquires ownership of stock in the Company that, together
with the stock already held by such Person, constitutes more than 50% of the total voting power of the stock of the Company; provided,
however, that for purposes of this subsection (i), the acquisition of additional stock by any Person who is considered to own more
than 50% of the total voting power of the stock of the Company before the acquisition will not be considered a Change in Control;
or

 

    	 

    	 

    

 

		(ii)	The individuals who constitute the members of the Board cease, by reason of a financing, merger,
combination, acquisition, takeover or other non-ordinary course transaction affecting the Company, to constitute at least fifty-one
percent (51%) of the members of the Board; or

 

		(iii)	The consummation of any of the following events: (A) a change in the ownership of a substantial
portion of the Company’s assets, which occurs on the date that any Person acquires (or has acquired during the twelve (12)
month period ending on the date of the most recent acquisition by such Person) assets from the Company that have a total gross
fair market value equal to or more than 50% of the total gross fair market value of all of the assets of the Company immediately
prior to such acquisition or acquisitions, (B) a merger, consolidation or reorganization involving the Company, where either or
both of the events described in clauses (i) or (ii) above would be the result, or (C) a liquidation or dissolution of or appointment
of a receiver, rehabilitator, conservator or similar person for, or the filing by a third party of an involuntary bankruptcy against,
the Company. For purposes of this subsection (iii), the following will not constitute a change in the ownership of a substantial
portion of the Company’s assets or a Change in Control: (A) a transfer to an entity that is controlled by the Company’s
stockholders immediately after the transfer, or (B) a transfer of assets by the Company to: (1) a stockholder of the Company (immediately
before the asset transfer) in exchange for or with respect to the Company’s stock, (2) an entity, 50% or more of the total
value or voting power of which is owned, directly or indirectly, by the Company, (3) a Person that owns, directly or indirectly,
50% or more of the total value or voting power of all the outstanding stock of the Company, or (4) an entity, at least 50% of the
total equity or voting power of which is owned, directly or indirectly, by a Person described in subsection (iii)(B)(3) above.
For purposes of this subsection (iii), gross fair market value means the value of the assets of the Company, or the value of the
assets being disposed of, determined without regard to any liabilities associated with such assets.

 

For purposes of this
Section 2(g), persons will be considered to be acting as a group if they are owners of a corporation or other entity that enters
into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company.

 

(h)“Code”
means the Internal Revenue Code of 1986, as amended. Any reference to a section of the Code herein will
be a reference to any successor or amended section of the Code.

 

    	-2-

    	 

    

 

(i)“Committee”
means a committee of Directors or of other individuals satisfying Applicable Laws appointed by the Board
in accordance with Section 4 hereof.

 

(j)“Common
Stock” means the common stock, par value $0.0001 per share, of the Company.

 

(k)“Company” means
Neurotrope, Inc., a Nevada corporation, or any successor thereto.

 

(l)“Consultant”
means any person, including an advisor, engaged by the Company or a Parent, Subsidiary or Affiliate to render services to such
entity.

 

(m)“Determination
Date” means the latest possible date that will not jeopardize the qualification of an Award granted under the Plan as
“performance-based compensation” under Section 162(m) of the Code.

 

(n)“Director”
means a member of the Board.

 

(o)“Disability”
means permanent and total disability as defined in Section 22(e)(3) of the Code, provided that
in the case of Awards other than Incentive Stock Options, the Administrator in its discretion may determine whether a permanent
and total disability exists in accordance with uniform and non-discriminatory standards adopted by the Administrator from time
to time.

 

(p)“Effective
Date” shall have the meaning set forth in Section 18 hereof.

 

(q)“Employee”
means any person, including Officers and Directors, employed by the Company or any Parent, Subsidiary or Affiliate of the Company.
Neither service as a Director nor payment of a director’s fee by the Company will be sufficient to constitute “employment”
by the Company.

 

(r)“Exchange
Act” means the Securities Exchange Act of 1934, as amended.

 

(s)“Exchange
Program” means a program under which (i) outstanding Awards are surrendered or cancelled in exchange for Awards of the
same type (which may have lower exercise prices and different terms), Awards of a different type, and/or cash, (ii) Participants
would have the opportunity to transfer any outstanding Awards to a financial institution or other person or entity selected by
the Administrator, and/or (iii) the exercise price of an outstanding Award is reduced. The Administrator will determine the terms
and conditions of any Exchange Program in its sole discretion.

 

(t)“Fair
Market Value” means, as of any date, the value of the Common Stock as the Administrator may
determine in good faith, by reference to the closing price of such stock on any established stock exchange or on a national market
system on the day of determination, if the Common Stock is so listed on any established stock exchange or on a national market
system. If the Common Stock is not listed on any established stock exchange or on a national market system, the value of the Common
Stock will be determined as the Administrator may determine in good faith.

 

    	-3-

    	 

    

 

(u)“Fiscal
Year” means the fiscal year of the Company.

 

(v)“Incentive
Stock Option” means an Option that by its terms qualifies and is otherwise intended to qualify as an incentive stock
option within the meaning of Section 422 of the Code and the regulations promulgated thereunder.

 

(w)“Nonstatutory
Stock Option” means an Option that by its terms does not qualify or is not intended to qualify as an Incentive Stock
Option.

 

(x)“Officer”
means a person who is an officer of the Company within the meaning of Section 16 of the Exchange Act and the rules and regulations
promulgated thereunder.

 

(y)“Option”
means a stock option granted pursuant to Section 6 hereof.

 

(z)“Parent”
means a “parent corporation,” whether now or hereafter existing, as defined in Section 424(e) of the Code.

 

(aa)“Participant”
means the holder of an outstanding Award.

 

(bb)“Performance
Goals” will have the meaning set forth in Section 11 hereof.

 

(cc)“Performance
Period” means any Fiscal Year of the Company or such other period as determined by the Administrator in its sole discretion.

 

(dd)“Performance
Share” means an Award denominated in Shares which may be earned in whole or in part upon attainment of Performance Goals
or other vesting criteria as the Administrator may determine pursuant to Section 10 hereof.

 

(ee)“Performance
Unit” means an Award which may be earned in whole or in part upon attainment of Performance Goals or other vesting criteria
as the Administrator may determine and which may be settled for cash, Shares or other securities or a combination of the foregoing
pursuant to Section 10 hereof.

 

(ff)“Period
of Restriction” means the period during which transfers of Shares of Restricted Stock are subject to restrictions and,
therefore, the Shares are subject to a substantial risk of forfeiture. Such restrictions may be based on the passage of time, the
achievement of target levels of performance, or the occurrence of other events as determined by the Administrator.

 

(gg)“Plan”
means this 2013 Equity Incentive Plan.

 

(hh)“Restricted
Stock” means Shares issued pursuant to an Award of Restricted Stock under Section 8 hereof,
or issued pursuant to the early exercise of an Option.

 

(ii)“Restricted
Stock Unit” means a bookkeeping entry representing an amount equal to the Fair Market Value of one Share, granted pursuant
to Section 9 hereof. Each Restricted Stock Unit represents an unfunded and unsecured obligation of the Company.

 

    	-4-

    	 

    

 

(jj)“Rule
16b-3” means Rule 16b-3 of the Exchange Act or any successor to Rule 16b-3, as in effect when discretion is being exercised
with respect to the Plan.

 

(kk)“Section 16(b)”
means Section 16(b) of the Exchange Act.

 

(ll)“Service
Provider” means an Employee, Director, or Consultant.

 

(mm)“Share”
means a share of the Common Stock, as adjusted in accordance with Section 14 hereof.

 

(nn)“Stock
Appreciation Right” means an Award, granted alone or in connection with an Option, that pursuant to Section 7 is
designated as a Stock Appreciation Right.

 

(oo)“Subsidiary”
means a “subsidiary corporation,” whether now or hereafter existing, as defined in Section 424(f) of the Code.

 

3.Stock Subject to the Plan.

 

(a)Subject to the
provisions of Section 14 hereof, the maximum aggregate number of Shares that may be awarded and sold under the Plan is Seven
Million (7,000,000) Shares. The Shares may be authorized, but unissued, or reacquired Common
Stock.

 

(b)Lapsed Awards.
If an Award expires or becomes unexercisable without having been exercised in full, or, with respect to Restricted Stock, Restricted
Stock Units, Performance Shares or Performance Units, is forfeited to or repurchased by the Company, the unpurchased Shares (or
for Awards other than Options and Stock Appreciation Rights, the forfeited or repurchased Shares) which were subject thereto will
become available for future grant or sale under the Plan (unless the Plan has terminated). Upon exercise
of a Stock Appreciation Right settled in Shares, the gross number of Shares covered by the portion of the Award so exercised will
cease to be available under the Plan. Shares that have actually been issued under the Plan under any Award will not be returned
to the Plan and will not become available for future distribution under the Plan; provided, however, that if unvested Shares of
Restricted Stock, Restricted Stock Units, Performance Shares or Performance Units are repurchased by the Company or are forfeited
to the Company, such Shares will become available for future grant under the Plan. Shares used to pay the tax and/or exercise price
of an Award will become available for future grant or sale under the Plan. To the extent an Award under the Plan is paid out in
cash rather than Shares, such cash payment will not result in reducing the number of Shares available for issuance under the Plan.
Notwithstanding the foregoing provisions of this Section 3(b), subject to adjustment provided in Section 14
hereof, the maximum number of Shares that may be issued upon the exercise of Incentive Stock Options will equal the aggregate Share
number stated in Section 3(a) above, plus, to the extent allowable under Section 422 of the Code, any Shares that become
available for issuance under the Plan under this Section 3(b).

 

(c)Share Reserve.
The Company, during the term of this Plan, will at all times reserve and keep available such number of Shares as will be sufficient
to satisfy the requirements of the Plan.

 

    	-5-

    	 

    

 

4.Administration
of the Plan.

 

(a)Procedure.

 

		(i)	Multiple Administrative Bodies. Different Committees with respect to different groups of
Service Providers may administer the Plan.

 

		(ii)	Section 162(m). To the extent that the Administrator determines it to be desirable
to qualify Awards granted hereunder as “performance-based compensation” within the meaning of Section 162(m) of
the Code, and if the Company is then a “publicly held corporation” as defined therein, the Plan will be administered
by a Committee of two (2) or more “outside directors” within the meaning of Section 162(m) of the Code.

 

		(iii)	Rule 16b-3. To the extent desirable to qualify transactions hereunder as exempt under Rule
16b-3, the transactions contemplated hereunder will be structured to satisfy the requirements for exemption under Rule 16b-3.

 

		(iv)	Other Administration. Other than as provided above, the Plan will be administered by (A) the
Board or (B) a Committee, which committee will be constituted to satisfy Applicable Laws.

 

(b)Powers of
the Administrator. Subject to the provisions of the Plan, and in the case of a Committee, subject to the specific duties delegated
by the Board to such Committee, the Administrator will have the authority, in its discretion:

 

		(i)	to determine the Fair Market Value;

 

		(ii)	to select the Service Providers to whom Awards may be granted hereunder;

 

		(iii)	to determine the terms and condition, not inconsistent with the terms of the Plan, of any Award
granted hereunder;

 

		(iv)	to institute an Exchange Program and to determine the terms and conditions,
not inconsistent with the terms of the Plan, for (1) the surrender or cancellation of outstanding Awards
in exchange for Awards of the same type, Awards of a different type, and/or cash, (2) the transfer of outstanding Awards to a financial
institution or other person or entity, or (3) the reduction of the exercise price of outstanding Awards;

 

		(v)	to construe and interpret the terms of the Plan and Awards granted pursuant to the Plan;

 

		(vi)	to prescribe, amend and rescind rules and regulations relating to the Plan, including rules and
regulations relating to sub-plans established for the purpose of satisfying applicable foreign laws;

 

		(vii)	to modify or amend each Award (subject to Section 19(c) hereof);

 

    	-6-

    	 

    

 

		(viii)	to authorize any person to execute on behalf of the Company any instrument required to effect the
grant of an Award previously granted by the Administrator;

 

		(ix)	to allow a Participant to defer the receipt of the payment of cash or the delivery of Shares that
would otherwise be due to such Participant under an Award pursuant to such procedures as the Administrator may determine; and

 

		(x)	to make all other determinations deemed necessary or advisable for administering the Plan.

 

(c)Effect of
Administrator’s Decision. The Administrator’s decisions, determinations, and interpretations will be final
and binding on all Participants and any other holders of Awards.

 

5.Eligibility.
Nonstatutory Stock Options, Restricted Stock, Restricted Stock Units, Stock Appreciation Rights, Performance Units, Performance
Shares, and such other cash or stock awards as the Administrator determines may be granted to Service Providers. Incentive Stock
Options may be granted only to Employees.

 

6.Stock Options.

 

(a)Limitations.

 

		(i)	Each Option will be designated in the Award Agreement as either an Incentive Stock Option or a
Nonstatutory Stock Option. However, notwithstanding such designation, to the extent that the aggregate Fair Market Value of the
Shares with respect to which Incentive Stock Options are exercisable for the first time by the Participant during any calendar
year (under all plans of the Company and any Parent or Subsidiary) exceeds $100,000 (U.S.), such Options will be treated as Nonstatutory
Stock Options. For purposes of this Section 6(a), Incentive Stock Options will be taken into account in the order in which
they were granted. The Fair Market Value of the Shares will be determined as of the time the Option with respect to such Shares
is granted.

 

		(ii)	The Administrator will have complete discretion to determine the number of Shares subject to an
Option granted to any Participant.

 

(b)Term of Option.
The Administrator will determine the term of each Option in its sole discretion; provided, however,
that the term will be no more than ten (10) years from the date of grant thereof. Moreover, in the case of an Incentive
Stock Option granted to a Participant who, at the time the Incentive Stock Option is granted, owns stock representing more than
10% of the total combined voting power of all classes of stock of the Company or any Parent or Subsidiary, the term of the Incentive
Stock Option will be five (5) years from the date of grant or such shorter term as may be provided in the Award Agreement.

 

    	-7-

    	 

    

 

(c)Option Exercise
Price and Consideration.

 

		(i)	Exercise Price. The per share exercise price for the Shares to be issued pursuant to exercise
of an Option will be determined by the Administrator, but will be no less than 100% of the Fair Market
Value per Share on the date of grant. In addition, in the case of an Incentive Stock Option granted to an Employee who,
at the time the Incentive Stock Option is granted, owns stock representing more than 10% of the voting power of all classes of
stock of the Company or any Parent or Subsidiary, the per Share exercise price will be no less than 110% of the Fair Market Value
per Share on the date of grant. Notwithstanding the foregoing provisions of this Section 6(c), Options
may be granted with a per Share exercise price of less than 100% of the Fair Market Value per Share on the date of grant pursuant
to a transaction described in, and in a manner consistent with, Section 424(a) of the Code. 

 

		(ii)	Waiting Period and Exercise Dates. At the time an Option is granted, the Administrator will
fix the period within which the Option may be exercised and will determine any conditions that must be satisfied before the Option
may be exercised.

 

		(iii)	Form of Consideration. The Administrator will determine the acceptable form(s) of consideration
for exercising an Option, including the method of payment, to the extent permitted by Applicable Laws.

 

(d)Exercise
of Option.

 

		(i)	Procedure for Exercise; Rights as a Stockholder. Any Option granted hereunder will be exercisable
according to the terms of the Plan and at such times and under such conditions as determined by the Administrator and set forth
in the Award Agreement. An Option may not be exercised for a fraction of a Share.

 

An Option
will be deemed exercised when the Company receives: (i) notice of exercise (in such form as the Administrator specifies from
time to time) from the person entitled to exercise the Option, and (ii) full payment for the Shares with respect to which
the Option is exercised (together with any applicable withholding taxes). No adjustment will be made for a dividend or other right
for which the record date is prior to the date the Shares are issued, except as provided in Section 14 hereof.

 

		(ii)	Termination of Relationship as a Service Provider. If a Participant ceases to be a Service
Provider, other than upon the Participant’s termination as the result of the Participant’s death or Disability, the
Participant may exercise his or her Option within such period of time as is specified in the Award Agreement to the extent that
the Option is vested on the date of termination (but in no event later than the expiration of the term of such Option as set forth
in the Award Agreement). In the absence of a specified time in the Award Agreement, the Option will remain exercisable for three
(3) months following the Participant’s termination. Unless otherwise provided by the Administrator, if on the date of termination
the Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option will revert
to the Plan. If after termination the Participant does not exercise his or her Option within the time specified by the Administrator,
the Option will terminate, and the Shares covered by such Option will revert to the Plan.

 

    	-8-

    	 

    

 

		(iii)	Disability of Participant. If a Participant ceases to be a Service Provider as a result
of the Participant’s Disability, the Participant may exercise his or her Option within such period of time as is specified
in the Award Agreement to the extent the Option is vested on the date of termination (but in no event later than the expiration
of the term of such Option as set forth in the Award Agreement). In the absence of a specified time in the Award Agreement, the
Option will remain exercisable for six (6) months following the Participant’s termination. Unless otherwise provided by the
Administrator, if on the date of termination the Participant is not vested as to his or her entire Option, the Shares covered by
the unvested portion of the Option will revert to the Plan. If after termination the Participant does not exercise his or her Option
within the time specified herein, the Option will terminate, and the Shares covered by such Option will revert to the Plan.

 

		(iv)	Death of Participant. If a Participant dies while a Service Provider, the Option may be
exercised within such period of time as is specified in the Award Agreement to the extent that the Option is vested on the date
of death (but in no event may the option be exercised later than the expiration of the term of such Option as set forth in the
Award Agreement), by the Participant’s designated beneficiary, provided such beneficiary has been designated prior to Participant’s
death in a form acceptable to the Administrator. If no such beneficiary has been designated by the Participant, then such Option
may be exercised by the personal representative of the Participant’s estate or by the person(s) to whom the Option is transferred
pursuant to the Participant’s will or in accordance with the laws of descent and distribution. In the absence of a specified
time in the Award Agreement, the Option will remain exercisable for six (6) months following Participant’s death. Unless
otherwise provided by the Administrator, if at the time of death Participant is not vested as to his or her entire Option, the
Shares covered by the unvested portion of the Option will continue to vest in accordance with the Award Agreement. If the Option
is not so exercised within the time specified herein, the Option will terminate, and the Shares covered by such Option will revert
to the Plan.

 

7.Stock Appreciation
Rights.

 

(a)Grant of
Stock Appreciation Rights. Subject to the terms and conditions of the Plan, a Stock Appreciation Right may be granted to Service
Providers at any time and from time to time as will be determined by the Administrator, in its sole discretion.

 

    	-9-

    	 

    

 

(b)Number of
Shares. The Administrator will have complete discretion to determine the number of Stock Appreciation Rights granted to any
Participant.

 

(c)Exercise
Price and Other Terms. The Administrator, subject to the provisions of the Plan, will have complete discretion to determine
the terms and conditions of Stock Appreciation Rights granted under the Plan; provided, however, that the
exercise price will be not less than 100% of the Fair Market Value of a Share on the date of grant. 

 

(d)Stock Appreciation
Rights Agreement. Each Stock Appreciation Right grant will be evidenced by an Award Agreement that will specify the exercise
price, the term of the Stock Appreciation Right, the conditions of exercise, and such other terms and conditions as the Administrator,
in its sole discretion, will determine.

 

(e)Expiration
of Stock Appreciation Rights. A Stock Appreciation Right granted under the Plan will expire upon the date determined by the
Administrator, in its sole discretion, and set forth in the Award Agreement; provided, however, that
the term will be no more than ten (10) years from the date of grant thereof. Notwithstanding the foregoing, the rules of
Section 6(d) above also will apply to Stock Appreciation Rights.

 

(f)Payment of
Stock Appreciation Right Amount. Upon exercise of a Stock Appreciation Right, a Participant will be entitled to receive payment
from the Company in an amount determined by multiplying:

 

		(i)	The difference between the Fair Market Value of a Share on the date of exercise over the exercise
price; times

 

		(ii)	The number of Shares with respect to which the Stock Appreciation Right is exercised.

 

At the discretion of
the Administrator, the payment upon Stock Appreciation Right exercise may be in cash, in Shares of equivalent value, or in some
combination thereof.

 

8.Restricted Stock.

 

(a)Grant of
Restricted Stock. Subject to the terms and provisions of the Plan, the Administrator, at any time and from time to time, may
grant Shares of Restricted Stock to Service Providers in such amounts as the Administrator, in its sole discretion, will determine.

 

(b)Restricted
Stock Agreement. Each Award of Restricted Stock will be evidenced by an Award Agreement that will specify the Period of Restriction,
the number of Shares granted, and such other terms and conditions as the Administrator, in its sole discretion, will determine.

 

(c)Transferability.
Except as provided in this Section 8, Shares of Restricted Stock may not be sold, transferred, pledged, assigned, or otherwise
alienated or hypothecated until the end of the applicable Period of Restriction.

 

    	-10-

    	 

    

 

(d)Other Restrictions.
The Administrator, in its sole discretion, may impose such other restrictions on Shares of Restricted Stock as it may deem advisable
or appropriate.

 

(e)Removal of
Restrictions. Except as otherwise provided in this Section 8, Shares of Restricted Stock covered by each Restricted Stock grant
made under the Plan will be released from escrow as soon as practicable after the last day of the Period of Restriction. The
Administrator, in its discretion, may accelerate the time at which any restrictions will lapse or be removed.

 

(f)Voting Rights.
During the Period of Restriction, Service Providers holding Shares of Restricted Stock granted hereunder may exercise full voting
rights with respect to those Shares, unless the Administrator determines otherwise.

 

(g)Dividends
and Other Distributions. During the Period of Restriction, Service Providers holding Shares of Restricted Stock will be entitled
to receive all dividends and other distributions paid with respect to such Shares unless otherwise provided in the Award Agreement.
If any such dividends or distributions are paid in Shares, the Shares will be subject to the same restrictions on transferability
and forfeitability as the Shares of Restricted Stock with respect to which they were paid.

 

(h)Return of
Restricted Stock to Company. On the date set forth in the Award Agreement, the Restricted Stock for which restrictions have
not lapsed will revert to the Company and again will become available for grant under the Plan.

 

(i)Section 162(m)
Performance Restrictions. For purposes of qualifying grants of Restricted Stock as “performance-based compensation”
under Section 162(m) of the Code, the Administrator, in its discretion, may set restrictions based upon the achievement of
Performance Goals. The Performance Goals will be set by the Administrator on or before the Determination Date. In granting Restricted
Stock which is intended to qualify under Section 162(m) of the Code, the Administrator will follow any procedures determined
by it from time to time to be necessary or appropriate to ensure qualification of the Award under Section 162(m) of the Code
(e.g., in determining the Performance Goals).

 

9.Restricted Stock
Units.

 

(a)Grant.
Restricted Stock Units may be granted at any time and from time to time as determined by the Administrator. Each Restricted Stock
Unit grant will be evidenced by an Award Agreement that will specify such other terms and conditions as the Administrator, in its
sole discretion, will determine, including all terms, conditions, and restrictions related to the grant, the number of Restricted
Stock Units and the form of payout, which, subject to Section 9(d) hereof, may be left to the discretion of the Administrator.

 

(b)Vesting Criteria
and Other Terms. The Administrator will set vesting criteria in its discretion, which, depending on the extent to which the
criteria are met, will determine the number of Restricted Stock Units that will be paid out to the Participant. After
the grant of Restricted Stock Units, the Administrator, in its sole discretion, may reduce or waive any restrictions for such Restricted
Stock Units. Each Award of Restricted Stock Units will be evidenced by an Award Agreement that will specify the vesting
criteria, and such other terms and conditions as the Administrator, in its sole discretion will determine. The
Administrator, in its discretion, may accelerate the time at which any restrictions will lapse or be removed.

 

    	-11-

    	 

    

 

(c)Earning Restricted
Stock Units. Upon meeting the applicable vesting criteria, the Participant will be entitled to receive a payout as specified
in the Award Agreement.

 

(d)Form and
Timing of Payment. Payment of earned Restricted Stock Units will be made as soon as practicable after the date(s) set forth
in the Award Agreement. The Administrator, in its sole discretion, may pay earned Restricted Stock Units in cash, Shares, or a
combination thereof. Shares represented by Restricted Stock Units that are fully paid in cash again will be available for grant
under the Plan.

 

(e)Cancellation.
On the date set forth in the Award Agreement, all unearned Restricted Stock Units will be forfeited to the Company.

 

(f)Section 162(m)
Performance Restrictions. For purposes of qualifying grants of Restricted Stock Units as “performance-based compensation”
under Section 162(m) of the Code, the Administrator, in its discretion, may set restrictions based upon the achievement of
Performance Goals. The Performance Goals will be set by the Administrator on or before the Determination Date. In granting Restricted
Stock Units which are intended to qualify under Section 162(m) of the Code, the Administrator will follow any procedures determined
by it from time to time to be necessary or appropriate to ensure qualification of the Award under Section 162(m) of the Code
(e.g., in determining the Performance Goals).

 

10.Performance
Units and Performance Shares.

 

(a)Grant of
Performance Units/Shares. Performance Units and Performance Shares may be granted to Service Providers at any time and from
time to time, as will be determined by the Administrator, in its sole discretion. The Administrator will have complete discretion
in determining the number of Performance Units/Shares granted to each Participant.

 

(b)Value of
Performance Units/Shares. Each Performance Unit will have an initial value that is established by the Administrator on or before
the date of grant. Each Performance Share will have an initial value equal to the Fair Market Value of a Share on the date of grant.

 

(c)Performance
Objectives and Other Terms. The Administrator will set performance objectives or other vesting provisions. The Administrator
may set vesting criteria based upon the achievement of Company-wide, business unit, or individual goals (including, but not limited
to, continued employment), or any other basis determined by the Administrator in its discretion. Each Award of Performance Units/Shares
will be evidenced by an Award Agreement that will specify the Performance Period, and such other terms and conditions as the Administrator,
in its sole discretion, will determine.

 

(d)Earning of
Performance Units/Shares. After the applicable Performance Period has ended, the holder of Performance Units/Shares will be
entitled to receive a payout of the number of Performance Units/Shares earned by the Participant over the Performance Period, to
be determined as a function of the extent to which the corresponding performance objectives or other vesting provisions have been
achieved. After the grant of a Performance Unit/Share, the Administrator, in its sole discretion, may
reduce or waive any performance objectives or other vesting provisions for such Performance Unit/Share.

 

    	-12-

    	 

    

 

(e)Form and
Timing of Payment of Performance Units/Shares. Payment of earned Performance Units/Shares will be made as soon as practicable
after the expiration of the applicable Performance Period. The Administrator, in its sole discretion, may pay earned Performance
Units/Shares in the form of cash, in Shares (which have an aggregate Fair Market Value equal to the value of the earned Performance
Units/Shares at the close of the applicable Performance Period) or in a combination thereof.

 

(f)Cancellation
of Performance Units/Shares. On the date set forth in the Award Agreement, all unearned or unvested Performance Units/Shares
will be forfeited to the Company, and again will be available for grant under the Plan.

 

(g)Section 162(m)
Performance Restrictions. For purposes of qualifying grants of Performance Units/Shares as “performance-based compensation”
under Section 162(m) of the Code, the Administrator, in its discretion, may set restrictions based upon the achievement of
Performance Goals. The Performance Goals will be set by the Administrator on or before the Determination Date. In granting Performance
Units/Shares which are intended to qualify under Section 162(m) of the Code, the Administrator will follow any procedures
determined by it from time to time to be necessary or appropriate to ensure qualification of the Award under Section 162(m)
of the Code (e.g., in determining the Performance Goals).

 

11.Performance-Based
Compensation Under Code Section 162(m).

 

(a)General.
If the Administrator, in its discretion, decides to grant an Award intended to qualify as “performance-based compensation”
under Code Section 162(m), the provisions of this Section 11 will control over any contrary provision in the Plan; provided, however,
that the Administrator may in its discretion grant Awards that are not intended to qualify as “performance-based compensation”
under Section 162(m) of the Code to such Participants that are based on Performance Goals or other specific criteria or goals but
that do not satisfy the requirements of this Section 11.

 

(b)Performance
Goals. The granting and/or vesting of Awards of Restricted Stock, Restricted Stock Units, Performance Shares and Performance
Units and other incentives under the Plan may be made subject to the attainment of performance goals relating to one or more business
criteria within the meaning of Code Section 162(m) and may provide for a targeted level or levels of achievement (“Performance
Goals”) including (i) earnings per Share, (ii) operating cash flow, (iii) operating
income, (iv) profit after-tax, (v) profit before-tax, (vi) return on assets, (vii) return on equity, (viii) return
on sales, (ix) revenue, and (x) total shareholder return. Any Performance Goals may be used to measure the performance
of the Company as a whole or a business unit of the Company and may be measured relative to a peer group or index. The Performance
Goals may differ from Participant to Participant and from Award to Award. Prior to the Determination Date, the Administrator will
determine whether any significant element(s) will be included in or excluded from the calculation of any Performance Goal with
respect to any Participant.

 

    	-13-

    	 

    

 

(c)Procedures.
To the extent necessary to comply with the performance-based compensation provisions of Code Section 162(m), with respect to any
Award granted subject to Performance Goals, within the first twenty-five percent (25%) of the Performance Period, but in no event
more than ninety (90) days following the commencement of any Performance Period (or such other time as may be required or permitted
by Code Section 162(m)), the Administrator will, in writing, (i) designate one or more Participants to whom an Award will be made,
(ii) select the Performance Goals applicable to the Performance Period, (iii) establish the Performance Goals, and amounts of such
Awards, as applicable, which may be earned for such Performance Period, and (iv) specify the relationship between Performance
Goals and the amounts of such Awards, as applicable, to be earned by each Participant for such Performance Period. Following the
completion of each Performance Period, the Administrator will certify in writing whether the applicable Performance Goals have
been achieved for such Performance Period. In determining the amounts earned by a Participant, the Administrator will have the
right to reduce or eliminate (but not to increase) the amount payable at a given level of performance to take into account additional
factors that the Administrator may deem relevant to the assessment of individual or corporate performance for the Performance Period.
A Participant will be eligible to receive payment pursuant to an Award for a Performance Period only if the Performance Goals for
such period are achieved. 

 

(d)Additional
Limitations. Notwithstanding any other provision of the Plan, any Award which is granted to a Participant and is intended to
constitute qualified performance based compensation under Code Section 162(m) will be subject to any additional limitations set
forth in the Code (including any amendment to Section 162(m)) or any regulations and ruling issued thereunder that are requirements
for qualification as qualified performance-based compensation as described in Section 162(m) of the Code, and the Plan will be
deemed amended to the extent necessary to conform to such requirements.

 

12.Leaves
of Absence. Unless the Administrator provides otherwise, vesting of Awards granted hereunder will
be suspended during any unpaid leave of absence. A Service Provider will not cease to be an Employee in the case of (i) any
leave of absence approved by the Company, or (ii) transfers between locations of the Company or between the Company, its Parent,
or any Subsidiary. For purposes of Incentive Stock Options, no such leave may exceed three (3) months, unless reemployment upon
expiration of such leave is guaranteed by statute or contract. If reemployment upon expiration of a leave of absence approved by
the Company is not so guaranteed, then six (6) months and one day following the commencement of such leave any Incentive Stock
Option held by the Participant will cease to be treated as an Incentive Stock Option and will be treated for tax purposes as a
Nonstatutory Stock Option.

 

13.Transferability
of Awards. Unless determined otherwise by the Administrator, an Award may not be sold, pledged, assigned, hypothecated, transferred,
or disposed of in any manner other than by will or by the laws of descent or distribution and may be exercised, during the lifetime
of the Participant, only by the Participant. If the Administrator makes an Award transferable, such Award may only be transferred
(i) by will, (ii) by the laws of descent and distribution, (iii) to a revocable trust, or (iii) as permitted by Rule 701 of the
Securities Act of 1933, as amended.

 

    	-14-

    	 

    

 

14.Adjustments;
Dissolution or Liquidation; Merger or Change in Control.

 

(a)Adjustments.
In the event that any dividend or other distribution (whether in the form of cash, Shares, other securities, or other property),
recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase,
or exchange of Shares or other securities of the Company, or other change in the corporate structure of the Company affecting the
Shares occurs, the Administrator, in order to prevent diminution or enlargement of the benefits or potential benefits intended
to be made available under the Plan, will adjust the number and class of Shares that may be delivered under the Plan and/or the
number, class, and price of Shares covered by each outstanding Award, and the numerical Share limits set forth in Sections 3,
6, 7, 8, 9 and 10 hereof.

 

(b)Dissolution
or Liquidation. In the event of the proposed dissolution or liquidation of the Company, the Administrator will notify each
Participant as soon as practicable prior to the effective date of such proposed transaction. To the extent it has not been previously
exercised, an Award will terminate immediately prior to the consummation of such proposed action.

 

(c)Change in
Control. In the event of a merger or Change in Control, each outstanding Award will be treated as
the Administrator determines, including, without limitation, that each Award will be assumed or an equivalent option or right substituted
by the successor corporation or a Parent or Subsidiary of the successor corporation (the “Successor Corporation”).
The Administrator will not be required to treat all Awards similarly in the transaction.

 

In the event that the
Successor Corporation does not assume or substitute for the Award, the Participant will fully vest in and have the right to exercise
all of his or her outstanding Options and Stock Appreciation Rights, including Shares as to which such Awards would not otherwise
be vested or exercisable, all restrictions on Restricted Stock will lapse, and, with respect to Restricted Stock Units, Performance
Shares and Performance Units, all Performance Goals or other vesting criteria will be deemed achieved at target levels and all
other terms and conditions met. In addition, if an Option or Stock Appreciation Right is not assumed or substituted for in the
event of a Change in Control, the Administrator will notify the Participant in writing or electronically that the Option or Stock
Appreciation Right will be fully vested and exercisable for a period of time determined by the Administrator in its sole discretion,
and the Option or Stock Appreciation Right will terminate upon the expiration of such period.

 

For the purposes of
this subsection (c), an Award will be considered assumed if, following the Change in Control, the Award confers the right to purchase
or receive, for each Share subject to the Award immediately prior to the Change in Control, the consideration (whether stock, cash,
or other securities or property) or, in the case of a Stock Appreciation Right upon the exercise of which the Administrator determines
to pay cash or a Performance Share or Performance Unit which the Administrator can determine to pay in cash, the fair market value
of the consideration received in the merger or Change in Control by holders of Common Stock for each Share held on the effective
date of the transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders
of a majority of the outstanding Shares); provided, however, that if such consideration received in the Change in Control is not
solely common stock of the Successor Corporation, the Administrator may, with the consent of the Successor Corporation, provide
for the consideration to be received upon the exercise of an Option or Stock Appreciation Right or upon the payout of a Performance
Share or Performance Unit, for each Share subject to such Award (or in the case of Performance Units, the number of implied shares
determined by dividing the value of the Performance Units by the per share consideration received by holders of Common Stock in
the Change in Control), to be solely common stock of the Successor Corporation equal in fair market value to the per share consideration
received by holders of Common Stock in the Change in Control.

 

    	-15-

    	 

    

 

Notwithstanding anything
in this Section 14(c) to the contrary, an Award that vests, is earned or paid-out upon the satisfaction of one or more Performance
Goals will not be considered assumed if the Company or its successor modifies any of such Performance Goals without the Participant’s
consent; provided, however, a modification to such Performance Goals only to reflect the Successor Corporation’s post-Change
in Control corporate structure will not be deemed to invalidate an otherwise valid Award assumption.

 

15.Tax Withholding

 

(a)Withholding
Requirements. Prior to the delivery of any Shares or cash pursuant to an Award (or exercise thereof), the Company will have
the power and the right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy
federal, state, local, foreign or other taxes (including the Participant’s FICA obligation) required to be withheld with
respect to such Award (or exercise thereof).

 

(b)Withholding
Arrangements. The Administrator, in its sole discretion and pursuant to such procedures as it may
specify from time to time, may permit a Participant to satisfy such tax withholding obligation, in whole or in part by (without
limitation) (i) paying cash, (ii) electing to have the Company withhold otherwise deliverable cash or Shares having a Fair
Market Value equal to the minimum amount required to be withheld, (iii) delivering to the Company already-owned Shares having a
Fair Market Value equal to the amount required to be withheld, or (iv) selling a sufficient number of Shares otherwise deliverable
to the Participant through such means as the Administrator may determine in its sole discretion (whether through a broker or otherwise)
equal to the amount required to be withheld. The amount of the withholding requirement will be deemed to include any amount which
the Administrator agrees may be withheld at the time the election is made, not to exceed the amount determined by using the maximum
federal, state or local marginal income tax rates applicable to the Participant with respect to the Award on the date that the
amount of tax to be withheld is to be determined. The Fair Market Value of the Shares to be withheld or delivered will be determined
as of the date that the taxes are required to be withheld.

 

16.No
Effect on Employment or Service. Neither the Plan nor any Award will confer upon a Participant any right with respect to continuing
the Participant’s relationship as a Service Provider with the Company, nor will they interfere in any way with the Participant’s
right or the Company’s right to terminate such relationship at any time, with or without cause, to the extent permitted by
Applicable Laws.

 

17.Date of Grant.
The date of grant of an Award will be, for all purposes, the date on which the Administrator makes the determination granting such
Award, or such other later date as is determined by the Administrator. Notice of the determination will be provided to each Participant
within a reasonable time after the date of such grant.

 

    	-16-

    	 

    

 

18.Term of Plan.
Subject to Section 22 hereof, the Plan will become effective upon its adoption by the Board (the “Effective Date”).
It will continue in effect for a term of ten (10) years unless terminated earlier under Section 19 hereof; provided,
however, that such expiration shall not affect Awards then outstanding, and the terms and conditions of this Plan shall continue
to apply to such Awards.

 

19.Amendment and
Termination of the Plan.

 

(a)Amendment
and Termination. The Administrator may at any time amend, alter, suspend or terminate the Plan.

 

(b)Stockholder
Approval. The Company will obtain stockholder approval of the Plan and any Plan amendment to the extent necessary or desirable
to comply with Applicable Laws.

 

(c)Effect of
Amendment or Termination. No amendment, alteration, suspension, or termination of the Plan will impair the rights of any Participant,
unless mutually agreed otherwise between the Participant and the Administrator, which agreement must be in writing and signed by
the Participant and the Company. Termination of the Plan will not affect the Administrator’s ability to exercise the powers
granted to it hereunder with respect to Awards granted under the Plan prior to the date of such termination.

 

20.Conditions
Upon Issuance of Shares.

 

(a)Legal Compliance.
Shares will not be issued pursuant to the exercise of an Award unless the exercise of such Award and the issuance and delivery
of such Shares will comply with Applicable Laws and will be further subject to the approval of counsel for the Company with respect
to such compliance.

 

(b)Investment
Representations. As a condition to the exercise of an Award, the Company may require the person exercising such Award to represent
and warrant at the time of any such exercise that the Shares are being purchased only for investment and without any present intention
to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is required.

 

(c)Restrictive
Legends. All Award Agreements and all securities of the Company issued pursuant thereto shall bear such legends regarding restrictions
on transfer and such other legends as the appropriate officer of the Corporation shall determine to be necessary or advisable to
comply with applicable securities and other laws.

 

21.Inability to
Obtain Authority. The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority
is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, will relieve
the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority will not
have been obtained.

 

    	-17-

    	 

    

 

22.Stockholder
Approval. The Plan will be subject to approval by the stockholders of the Company within twelve (12) months after the date
the Plan is adopted by the Board. Such stockholder approval will be obtained in the manner and to the degree required under Applicable
Laws. In the event that stockholder approval is not obtained within twelve (12) months after the date the Plan is adopted by the
Board, the Plan and all Awards granted hereunder shall be void ab initio and of no effect. Notwithstanding any other provisions
of the Plan, no Awards shall be exercisable until the date of such stockholder approval.

 

23.Notification
of Election Under Section 83(b) of the Code. If any Service Provider shall, in connection with the acquisition of Shares under
the Plan, make the election permitted under Section 83(b) of the Code, such Service Provider shall notify the Company of such election
within ten (10) days of filing notice of the election with the Internal Revenue Service and provide the Company with a copy thereof,
in addition to any filing and a notification required pursuant to regulations issued under the authority of Section 83(b) of the
Code. A Service Provider shall not be permitted to make a Section 83(b) election with respect to an Award of a Restricted Stock
Unit.

 

24.Notification
Upon Disqualifying Disposition Under Section 421(b) of the Code. Each Service Provider shall notify the Company of any disposition
of Shares issued pursuant to the exercise of an Incentive Stock Option under the circumstances described in Section 421(b) of the
Code (relating to certain disqualifying dispositions), within ten (10) days of such disposition.

 

    	-18-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00221-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00221-of-00352.parquet"}]]